These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 23564925)

  • 1. Private firms form initiative to offer accurate and affordable TB tests.
    Kay M
    BMJ; 2013 Apr; 346():f2161. PubMed ID: 23564925
    [No Abstract]   [Full Text] [Related]  

  • 2. Market assessment of tuberculosis diagnostics in India in 2013.
    Maheshwari P; Chauhan K; Kadam R; Pujani A; Kaur M; Chitalia M; Dabas H; Perkins MD; Boehme CC; Denkinger CM; Raizada N; Ginnard J; Jefferson C; Pantoja A; Rupert S; Kik SV; Cohen C; Chedore P; Satyanarayana S; Pai M;
    Int J Tuberc Lung Dis; 2016 Mar; 20(3):304-13. PubMed ID: 27046709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Who must have tuberculosis screening? Characteristics of risk patients].
    MMW Fortschr Med; 2013 May; 155(9):16-8. PubMed ID: 23951641
    [No Abstract]   [Full Text] [Related]  

  • 4. [Economic expediency and medical efficiency of methods for active detection of tuberculosis].
    Karpov AV
    Probl Tuberk; 2000; (2):3-5. PubMed ID: 10838896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening health care workers with interferon-γ release assay versus tuberculin skin test: impact on costs and adherence to testing (the SWITCH study).
    Wrighton-Smith P; Sneed L; Humphrey F; Tao X; Bernacki E
    J Occup Environ Med; 2012 Jul; 54(7):806-15. PubMed ID: 22796924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance of commercial blood tests for the diagnosis of latent tuberculosis infection in children and adolescents.
    Bergamini BM; Losi M; Vaienti F; D'Amico R; Meccugni B; Meacci M; De Giovanni D; Rumpianesi F; Fabbri LM; Balli F; Richeldi L
    Pediatrics; 2009 Mar; 123(3):e419-24. PubMed ID: 19254978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Market assessment of tuberculosis diagnostics in South Africa, 2012-2013.
    TB Diagnostics Market Analysis Consortium
    Int J Tuberc Lung Dis; 2015 Feb; 19(2):216-22. PubMed ID: 25574922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunodiagnosis of tuberculosis: state of the art.
    Pinto LM; Grenier J; Schumacher SG; Denkinger CM; Steingart KR; Pai M
    Med Princ Pract; 2012; 21(1):4-13. PubMed ID: 22024473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. WHO recommends against inaccurate tuberculosis tests.
    Morris K
    Lancet; 2011 Jan; 377(9760):113-4. PubMed ID: 21226229
    [No Abstract]   [Full Text] [Related]  

  • 10. [Difficulties of TB diagnosis in children: QuantiFERON TB Gold In-Tube as useful tool].
    Grare M; Derelle J; Dailloux M; Laurain C
    Arch Pediatr; 2010 Jan; 17(1):77-85. PubMed ID: 19733468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of reverse transcription loop-mediated isothermal amplification in conjunction with ELISA-hybridization assay for molecular detection of Mycobacterium tuberculosis.
    Lee MF; Chen YH; Peng CF
    J Microbiol Methods; 2009 Feb; 76(2):174-80. PubMed ID: 19022304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of bronchoalveolar lavage enzyme-linked immunospot for diagnosis of smear-negative pulmonary tuberculosis.
    Li H; Yang L; Zheng CY; Wang J; Abdullah AS
    Int J Tuberc Lung Dis; 2012 Dec; 16(12):1668-73. PubMed ID: 23131267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An in-house RD1-based enzyme-linked immunospot-gamma interferon assay instead of the tuberculin skin test for diagnosis of latent Mycobacterium tuberculosis infection.
    Codecasa L; Mantegani P; Galli L; Lazzarin A; Scarpellini P; Fortis C
    J Clin Microbiol; 2006 Jun; 44(6):1944-50. PubMed ID: 16757583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cost-effectiveness of screening for latent tuberculosis in healthcare workers].
    Diomedi A
    Rev Chilena Infectol; 2013 Jun; 30(3):330. PubMed ID: 23877785
    [No Abstract]   [Full Text] [Related]  

  • 15. Feasibility and effectiveness of a public-private mix project for improved TB control in Delhi, India.
    Arora VK; Sarin R; Lönnroth K
    Int J Tuberc Lung Dis; 2003 Dec; 7(12):1131-8. PubMed ID: 14677887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is the T-cell-based interferon-gamma releasing assay feasible for diagnosis of latent tuberculosis infection in an intermediate tuberculosis-burden country?
    Dilektasli AG; Erdem E; Durukan E; Eyüboğlu FÖ
    Jpn J Infect Dis; 2010 Nov; 63(6):433-6. PubMed ID: 21099095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon-gamma release assay tests to rule out active tuberculosis.
    Janssens JP
    Eur Respir J; 2007 Jul; 30(1):183-4; author reply 184-5. PubMed ID: 17601979
    [No Abstract]   [Full Text] [Related]  

  • 18. Market assessment of tuberculosis diagnostics in China in 2012.
    Zhao YL; Pang Y; Xia H; Du X; Chin D; Huan ST; Dong HY; Zhang ZY; Ginnard J; Perkins MD; Boehme CC; Jefferson C; Pantoja A; Qin ZZ; Chedore P; Denkinger CM; Pai M; Kik SV;
    Int J Tuberc Lung Dis; 2016 Mar; 20(3):295-303. PubMed ID: 27046708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tuberculin skin test and QuantiFERON® assay in young children investigated for tuberculosis in South Africa.
    Moyo S; Isaacs F; Gelderbloem S; Verver S; Hawkridge AJ; Hatherill M; Tameris M; Geldenhuys H; Workman L; Pai M; Hussey G; Hanekom WA; Mahomed H
    Int J Tuberc Lung Dis; 2011 Sep; 15(9):1176-81, i. PubMed ID: 21943841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prevalence of pulmonary tuberculosis using different methods in group screenings.
    Beser E
    East Afr Med J; 1993 Dec; 70(12):768-71. PubMed ID: 8026349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.